(R)-Methyl 2-amino-3-(4-aminophenyl)propanoate dihydrochloride, 95.0%, 250mg

(2,6-dinitro-4-(trifluoromethyl)phenyl)glycine, 95.0%, 1g

(1R,3S)-3-Boc-Amino-cyclohexanecarboxylic acid, 95.0%, 1g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 2000 ml, 190 mm, 1 Piece

m-toluic acid, 98%, for synthesis, 250 g, plastic packaging.

4,4,5,5-Tetramethyl-2-(triphenylen-2-yl)-1,3,2-dioxaborolane>97.0%(HPLC)(N)1g

tert-Butyl ((1S,3S)-1-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)carbamate, 95%, 250mg

(6-((tert-Butoxycarbonyl)amino)pyridin-3-yl)boronic acid, 95.0%, 250mg

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-5-carboxylate, 95%, 250mg

2-(2-Fluoro-4-nitrophenyl)acetic acid, 98.0%, 100g

(1R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline, 95.0%, 5g

Benzeneacetonitrile, 3-[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-, 100mg

5-(Ethylamino)pyrazine-2-carbonitrile, 98%, 5g